Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paromomycin 14 vs 21 Days for Visceral Leishmaniasis
NCT00629031Phase 3Completed
- Sponsor
- Banaras Hindu University
- Start
- Feb 2008
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of paromomycin in visceral leishmaniasis (VL) (2 arms), sponsored by Banaras Hindu University. Primary endpoint: Final Cure Rate. Started Feb 2008; status: completed.
02
Drugs
paromomycin
03
Conditions
visceral leishmaniasis (VL)
Beyond the preview
Go deeper on NCT00629031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00629031.